UCFA
SRPT icon

United Capital Financial Advisors’s Sarepta Therapeutics SRPT Stock Holding History

United Capital Financial Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,895
Closed -$259K – 1728
2026
Q1 		$259K Buy
+11,895
New +$230K ﹤0.01% 1430
2021
Q2 		– Sell
-12,905
Closed -$962K – 1255
2021
Q1 		$962K Sell
12,905
-115
-0.9% -$10.6K 0.01% 682
2020
Q4 		$2.22M Buy
13,020
+889
+7% +$132K 0.01% 487
2020
Q3 		$1.71M Sell
12,131
-920
-7% -$140K 0.01% 535
2020
Q2 		$2.09M Sell
13,051
-2,063
-14% -$281K 0.02% 507
2020
Q1 		$1.48M Buy
+15,114
New +$1.73M 0.01% 552
2019
Q4 		– Sell
-15,223
Closed -$1.15M – 1421
2019
Q3 		$1.15M Sell
15,223
-400
-3% -$47.2K 0.01% 706
2019
Q2 		$2.37M Buy
15,623
+643
+4% +$78.1K 0.02% 572
2019
Q1 		$1.78M Buy
14,980
+288
+2% +$37K 0.01% 620
2018
Q4 		$1.6M Sell
14,692
-5,535
-27% -$692K 0.01% 609
2018
Q3 		$3.27M Sell
20,227
-90
-0.4% -$12.3K 0.02% 508
2018
Q2 		$2.69M Sell
20,317
-5,794
-22% -$546K 0.02% 527
2018
Q1 		$1.94M Sell
26,111
-10
-0% -$667 0.01% 599
2017
Q4 		$1.48M Buy
26,121
+650
+3% +$34.4K 0.01% 677
2017
Q3 		$1.16M Buy
25,471
+13
+0.1% +$520 0.01% 737
2017
Q2 		$858K Hold
25,458
– – 0.01% 803
2017
Q1 		$754K Hold
25,458
– – 0.01% 820
2016
Q4 		$698K Sell
25,458
-1
-0% -$40 0.01% 847
2016
Q3 		$1.56M Sell
25,459
-4,585
-15% -$139K 0.02% 653
2016
Q2 		$571K Hold
30,044
– – 0.01% 879
2016
Q1 		$586K Hold
30,044
– – 0.01% 831
2015
Q4 		$1.16M Hold
30,044
– – 0.01% 654
2015
Q3 		$965K Hold
30,044
– – 0.01% 702
2015
Q2 		$914K Buy
30,044
+833
+3% +$17K 0.01% 743
2015
Q1 		$356K Buy
+29,211
New +$389K ﹤0.01% 1019

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

United Capital Financial Advisors's SRPT Position: Q2 2026 in Review

United Capital Financial Advisors sold out of Sarepta Therapeutics (SRPT) in Q2 2026, closing a stake of 11,895 shares — an estimated $259K sold.

United Capital Financial Advisors first reported a position in SRPT in Q1 2015 and held it in 25 quarters. The position peaked at $3.27M in Q3 2018. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • United Capital Financial Advisors reported no remaining Sarepta Therapeutics position as of Q2 2026 after selling out during the quarter.
  • United Capital Financial Advisors sold 11,895 Sarepta Therapeutics shares in Q2 2026, an estimated $259K.
  • United Capital Financial Advisors first reported a position in Sarepta Therapeutics in Q1 2015 and held it in 25 quarters.
  • United Capital Financial Advisors's Sarepta Therapeutics position peaked at $3.27M in Q3 2018.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.